Small-cap pharmaceuticals to watch: Tyvaso, Axsome, and Exelixis.
ByAinvest
Wednesday, Feb 4, 2026 2:54 pm ET1min read
AXSM--
PTCT--
UTHR--
Small-cap pharmaceutical stocks are gaining attention as companies approach key clinical trial readouts and regulatory decisions. Terry Smith from Emerald Advisers highlights three companies: United Therapeutics, Axsome, and PTC Therapeutics. United Therapeutics' Tyvaso could double sales with a new drug targeting lung disease, while Axsome's depression treatment has shown promising results in late-stage trials. PTC Therapeutics is working on a treatment for spinal muscular atrophy, which could expand its revenue opportunities.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet